Utomilumab

Utomilumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Utomilumab is a fully human IgG2 monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9), being investigated for potential clinical anti-tumour activity.

Utomilumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Utomilumab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
AntibodySystem	17762345272 18162686757	biolab-reagents@atagenix.com	China	9809	58
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8012	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10036	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5353	58
Shanghai jerryxing Biomedical Technology Co., Ltd	17721492509	643638326@qq.com	China	5347	58
Changsha Fuzhen Biotechnology Co.，LTD	0731-13823398 13823398779	313359644@qq.com	China	3104	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	28118	58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd	17316404525	209533805@qq.com	China	9640	58

---

• Utomilumab
• Research Grade Utomilumab (DHG11001)
• PF 05082566|||PF-2566
• 1417318-27-4